Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
257 people get CBPO articles and Market Currents by email alert.
Get email alerts on CBPO »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
China Biologic Products: Steady Growth At A Cheap PriceKapitall • Sun, Jun 24, 2012 -
-
-
Promising Chinese Medical StockCabot • Mon, May 24, 2010 -
China Biologic Products Receives Forbes HonorChinaBio Today • Thu, Oct 22, 2009 -
-
-
China Biologic Products Raises $9.6 Million, Continues ExpansionChinaBio Today • Mon, Jun 8, 2009
-
-
-
China Biologic Continues Its Growth SpurtChinaBio Today • Fri, Apr 3, 2009
-
China Biologic's International Sales Raise Company MarginsChinaBio Today • Wed, Dec 24, 2008
-
China Biologic Settles for Smaller Stake in Qianfeng AcquisitionChinaBio Today • Sun, Dec 21, 2008
-
China Biologic's Q3: Still Going StrongChinaBio Today • Fri, Nov 14, 2008
-
China Biologic Buys Another Plasma-Based PharmaChinaBio Today • Fri, Oct 17, 2008
-
China Biologic to Buy Majority Interest in Plasma CompetitorChinaBio Today • Thu, Oct 2, 2008
-
China Biologic to Test New Plasma ProductChinaBio Today • Thu, Sep 18, 2008
-
China Biologic Reports Two SFDA SuccessesChinaBio Today • Fri, May 2, 2008
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
7 High Growth Healthcare Stocks With Strong Inventory TrendsKapitall • Wed, Dec 12, 2012
-
-
3 Stocks With Encouraging Accounting Signals Insiders Believe InKapitall • Wed, Oct 31, 2012
-
3 Biotech Stocks Holding Down The Debt And On Track For GrowthZetaKap • Tue, Sep 18, 2012 -
3 High-Growth Biotech Stocks With Encouraging Inventory TrendsKapitall • Mon, Aug 20, 2012
-
-
4 Undervalued Healthcare Stocks With Strong Inventory TrendsKapitall • Wed, Aug 15, 2012
-
3 Liquid Biotech Stocks With Impressive Growth ProjectionsZetaKap • Sun, Aug 12, 2012
-
-
7 China Stocks With Insider BuysMarkus Aarnio • Tue, Jul 10, 2012 -
-
-
-
-
7 High-Growth Healthcare Small Caps Being Bought Up By InsidersKapitall • Tue, Jun 5, 2012
-
3 Undervalued Stocks Being Snapped Up By InsidersKapitall • Mon, May 28, 2012
-
-
9 Rallying Biotech Stocks Being Snapped Up By Hedge FundsKapitall • Tue, May 15, 2012
-
PR Newswire (Jun 10, 2013)
-
PR Newswire (Jun 3, 2013)
-
PR Newswire (May 24, 2013)
-
PR Newswire (May 8, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (Mar 13, 2013)
-
PR Newswire (Mar 8, 2013)
-
PR Newswire (Jan 2, 2013)
-
PR Newswire (Nov 19, 2012)
-
PR Newswire (Nov 8, 2012)
-
PR Newswire (Nov 2, 2012)
-
at Fox Business (Aug 22, 2012)
-
at Fox Business (Aug 22, 2012)
-
at Fox Business (Aug 22, 2012)
-
PR Newswire (Aug 9, 2012)
-
PR Newswire (Aug 3, 2012)
-
PR Newswire (Jun 25, 2012)
CBPO vs. ETF Alternatives
Company Description
Currently, there's no company description for CBPO.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Friday, June 7, 12:45 PM
Midday top 10 gainers: OSH +23%. WSBF +19%. OPTT +17%. CSFS +14%. BDBD +13%. JKS +11%. ROSG +11%. THO +10%. ECTY +10%. KFS +9%.
Midday top 10 Losers: FSGI -56%. TIVO -17%. USM -17%. IRM -16%. ZQK -12%. JRCC -11%. LQDT -11%. AFFY -10%. CBPO -10%. TRUE -8%. Comment! [On the Move] - Friday, May 24, 11:22 AM China Biologic (CBPO -5.3%) slides on the news that on May 21 two of its shareholders sold its competitor, Shanghai RAAS, about 2.7M of its shares representing 9.9% of equity. CBPO says it had no knowledge of the deal, nor had there been any discussions with Shanghai RAAS. The sale looks to be questionable at best, considering that one of the shareholders' shareholding status was under dispute in a pending case in Hong Kong, and Shanghai RAAS was aware of that fact. Comment! [Global & FX, Healthcare]
- Thursday, May 9, 4:28 AM China Biologic (CBPO): Q1 EPS of $0.59 beats by $0.13. Revenue of $54M beats by $3.9M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, January 2, 2:51 PM China Biologic Products (CBPO -4.6%) slips after announcing earlier today that construction of a new production facility at its Guizhou Taibang subsidiary could be delayed due to slower-than-expected government approval of land use rights. The Company says it's working closely with local authorities to secure approval as soon as possible and will provide an update as soon as possible. CBPO had planned to commence work on the project in late 2012, with completion by mid-2014. Comment! [Global & FX, On the Move]
- Friday, July 15, 2011, 4:04 PM China Biologic Products (CBPO -6.5%) takes a hit today after receiving notification from the Guizhou Provincial Health Department that the government has suspended the company's blood collection activities in the province. The suspension affects four of six collection sites it runs, and the impact upon current business operations could be significant. Comment! [Healthcare, Global & FX, On the Move]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.